Key facts
- It has raised $9.7M; the latest was Early Stage VC ($5.4M) in Dec 2025.
- Notable investors include InterVest, Schmidt (South Korea), Quantum Ventures Korea, DSC Investment, SDB Investment — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Arcreal
- ·The full record, as it builds
Funding rounds
No funding rounds for Arcreal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arcreal
Developer of a three-dimensional dental application intended to transform the healthcare industry with cutting-edge technology. The company leverages technology to develop intraoral scanners, medical software, and dental platforms based on artificial intelligence and three-dimensional graphics, enabling dentists to access technology to increase efficiency and diagnoses.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2021
- Employees
- 10
- Website
- arcreal.com/
- Ownership
- Privately Held (backing)
Arcreal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arcreal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arcreal in its N-PORT filings yet. We sweep new filings monthly.